AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
58 hedge funds and large institutions have $84.5M invested in Aegerion Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
81% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 16
Holders
58
Holding in Top 10
1
Calls
$1.26M
Puts
$708K
Top Buyers
| 1 | +$1.46M | |
| 2 | +$1.04M | |
| 3 | +$1.03M | |
| 4 |
Citigroup
New York
|
+$160K |
| 5 |
FMA
FNY Managed Accounts
New York
|
+$86K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$816K | |
| 3 | -$390K | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$382K |
| 5 |
Two Sigma Investments
New York
|
-$248K |
